The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tips, Resources to Help Rheumatologists Educate Patients on Biologics and Biosimilars

Tips, Resources to Help Rheumatologists Educate Patients on Biologics and Biosimilars

February 15, 2017 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“This study emphasizes that some patients are at risk of poorly managing their biologic therapy. These patients should be identified and monitored to avoid major and perhaps life-threatening complications,” Dr. Rat says.

You Might Also Like
  • Biosimilars to Raise Unique Questions
  • Most Rheumatologists Want FDA to Better Regulate Biosimilars
  • Tips for Educating Patients in the Age of Biologics
Explore This Issue
February 2017
Also By This Author
  • 7 Tips That Dermatologists Want Rheumatologists to Know

Rheumatologists and their staff may need to remind patients more frequently about some of the misuse risks, Dr. Rat cautions.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Rheumatologists should remind patients to have patience with biologics in terms of allowing for effectiveness, managing side effects, and getting over the fear of self-injection, Dr. Askanase says.

5 Tips to Improve the Patient Education Discussion

1. Ask patients to bring a family member or friend with them, Dr. Troum advises. This gives the patient—who likely is still processing information about their disease—an objective person who will listen and ask questions regarding biologics. When a patient comes to the office alone initially, this sometimes means they must return for a second appointment to bring their companion. Dr. Troum is fine with this if it means they will be better informed about biologics.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

2. Update your approach as needed. Dr. Huston finds that focusing too much on the risks of biologics scares patients away and that a balanced discussion of benefits and risks is typically needed. He also finds that patients often have preconceived notions about the medication and need their misinformation corrected. He alters his discussion based on perceived patient fears and preferences. “Some patients express a lot of anxiety and want to review biologic therapy in great detail, and others just say, ‘Whatever you think is best, doc,’” Dr. Huston says.

You may also change your education depending on patients’ lifestyle issues and financial challenges, Dr. Field says.

3. Tap into seasoned patients as resources for new patients. “Developing a ‘network’ can be a game-changer for my patients,” Dr. Field says. “We have our experienced patients available for support to our newly diagnosed patients. Patients considering biologics can tour our infusion suite and are encouraged to chat with patients who are receiving infusion therapy at that very moment,” Dr. Field says. “Many patients develop friendships that are quite helpful through their RA treatment journey.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

4. Think about new, useful ways to present medication information. In addition to the usual discussion and written material, the U.S. National Library of Medicine suggests several other teaching tools, including podcasts, YouTube or other videos, PowerPoint presentations, posters or charts, models or props, group classes and trained peer educators.

“Appropriate, effective patient education really requires a multidisciplinary and integrative approach using several modalities,” Ms. Batterman says. For example, support and education programs offer an opportunity to obtain support from peers who understand the complex concerns of fellow patients, with the benefit of healthcare professionals gently guiding the discussion. Nurses can provide further clarification and answer questions; social workers can assess and further explore issues around coping with chronic illness and treatment, which can impact patients’ understanding, decisions and adherence in a profound way.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Biologics & Biosimilars, Drug Updates, Practice Management Tagged With: Biologics, Drugs, patient care, Practice Management, Quality, rheumatologist, rheumatology, Safety, therapy, TreatmentIssue: February 2017

You Might Also Like:
  • Biosimilars to Raise Unique Questions
  • Most Rheumatologists Want FDA to Better Regulate Biosimilars
  • Tips for Educating Patients in the Age of Biologics
  • The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.